Key result
Short-term PM2.5 exposure is linked to ~6% higher 4P-MACE odds per 10 µg/m³.
Why the study?
While short-term PM2.5 exposure is a recognised risk factor for acute cardiovascular events in the general population, data regarding its effects in high-risk populations with significant atherosclerotic risk are limited.
Does short-term ambient PM2.5 exposure increase the risk of four-point major adverse cardiovascular events (non-fatal MI, non-fatal stroke, HF hospitalisation, and all-cause death) in a high-risk atherosclerotic population in Thailand?
Case-Control (n=1,121)
Yes
Does short-term ambient PM2.5 exposure increase the risk of four-point major adverse cardiovascular events (non-fatal MI, non-fatal stroke, HF hospitalisation, and all-cause death) in a high-risk atherosclerotic population in Thailand?
Odds Ratio: 1.06 (95% CI 1.01–1.11)
p-value: p=<0.05
Short-term ambient PM2.5 exposure is significantly associated with a 6% to 8% increased odds of acute major adverse cardiovascular events per 10 µg/m³ increment in patients with high baseline atherosclerotic risk, underscoring the need to integrate air pollution mitigation into secondary cardiovascular prevention.
Short-term PM2.5 exposure was associated with higher 4P-MACE odds in high-risk patients; extends prior evidence but remains hypothesis-generating for targeted prevention.
OBJECTIVES: While particulate matter with a diameter ≤2.5 µm (PM(2.5)) is a recognised major modifiable risk factor with well-documented short-term impacts on acute cardiovascular events in the general population, data regarding its effects on high-risk populations with significant atherosclerotic risk are limited. This study aims to identify the association between short-term exposure to PM(2.5) and acute major cardiovascular events in Thailand. DESIGN: A time-stratified case-crossover design. SETTING: The nationwide Cohort Of patients with high Risk for cardiovascular Events-Thailand registry (CORE-Thailand registry). PARTICIPANTS: A total of 1121 individuals from the registry who experienced four-point major adverse cardiovascular events (4P-MACEs) between 2011 and 2019. PRIMARY OUTCOME MEASURE: The primary exposure was defined as short-term PM(2.5) exposure, with the primary outcome being a first-time MACE, which included acute myocardial infarction, stroke, heart failure hospitalisation and all-cause death. METHODS: Using a time-stratified case-crossover design, the analysed events included non-fatal myocardial infarction, non-fatal stroke, heart failure hospitalisation and all-cause death. Daily PM(2.5) concentrations during the event and control periods were obtained from nearby air quality monitors. Conditional logistic regression models assessed odds ratio (ORs) for 4P-MACE per 10 µg/m³ increase in PM(2.5) exposure over lag periods from 0 to 7 days. RESULTS: The participants had a mean age of 69.9 years and 55.8% were male. Most had pre-existing atherosclerotic cardiovascular diseases (74.6%), diabetes mellitus (58.4%), hypertension (98.1%) and dyslipidaemia (83.3%). Significant associations were observed for both single-day (lag 1 to lag 4) and average-days (lag 01 to 07) PM(2.5) exposures. A 10 µg/m³ increase in PM(2.5) was associated with increased odds of MACEs, with ORs of 1.06 (95% CI 1.01 - 1.11) for single-day lagged exposures and varying ORs from 1.06 to 1.08 for average-days lagged exposures (lags 01 to 04). CONCLUSIONS: Short-term PM(2.5) exposure significantly increased the risk of MACE in the Thai population with high atherosclerotic risk. These findings underscore the urgency of public health interventions aimed at mitigating air pollution exposure, especially among vulnerable groups. TRIAL REGISTRATION: The study is registered with the Thai Clinical Trials Registry (TCTR20130520001).
No takes yet. Share an insight, caveat, or question.
Wongcharoen et al. (2026) conducted a case-control in High atherosclerotic cardiovascular disease risk with four-point major adverse cardiovascular events (n=1,121). Short-term ambient PM2.5 exposure (per 10 µg/m³ increase over lag 0 to 7 days) vs. Self-matched control periods separated by a 4-week window was evaluated on First-time four-point major adverse cardiovascular event (4P-MACE: non-fatal myocardial infarction, non-fatal stroke, heart failure hospitalisation, and all-cause death) (OR 1.06, 95% CI 1.01-1.11, p=<0.05). Short-term PM2.5 exposure per 10 µg/m³ increase was associated with increased odds of 4P-MACE (OR 1.06, 95% CI 1.01-1.11 for single-day lags 1 to 4) in high-risk cardiovascular patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: